Protagenic Therapeutics, Inc.\new Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Protagenic Therapeutics, Inc.\new quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2013 to Q4 2023.
  • Protagenic Therapeutics, Inc.\new Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $7.07M, a 27.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $7.07M +$1.51M +27.2% Dec 31, 2023 10-K/A 2024-05-14
Q4 2022 $5.56M +$137K +2.53% Dec 31, 2022 10-K/A 2024-05-14
Q4 2021 $5.42M +$1.3M +31.5% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $4.12M +$418K +11.3% Dec 31, 2020 10-K 2022-04-07
Q4 2019 $3.7M +$661K +21.7% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $3.04M +$279K +10.1% Dec 31, 2018 10-K 2020-04-29
Q4 2017 $2.76M +$243K +9.64% Dec 31, 2017 10-K 2019-03-29
Q4 2016 $2.52M +$1.15M +83.7% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $1.37M +$445K +48% Dec 31, 2015 10-K/A 2017-05-08
Q2 2015 $22M +$171K +0.78% Jun 30, 2015 10-K 2015-09-25
Q4 2014 $927K Dec 31, 2014 8-K/A 2016-07-12
Q2 2014 $21.8M -$604K -2.69% Jun 30, 2014 10-K 2015-09-25
Q2 2013 $22.4M Jun 30, 2013 10-K 2014-10-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.